Ventas (NYSE:VTR) Sets New 52-Week High – Time to Buy?

Posted by Brenda Bartman on Jul 21st, 2026

Ventas, Inc. (NYSE:VTR – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $97.18 and last traded at $97.2480, with a volume of 189802 shares changing hands. The stock had previously closed at $96.25.

Analyst Ratings Changes

VTR has been the subject of a number of recent analyst reports. KeyCorp increased their target price on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Scotiabank dropped their price objective on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Raymond James Financial initiated coverage on Ventas in a report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 target price on the stock. Barclays started coverage on Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price target for the company. Finally, The Goldman Sachs Group restated a “buy” rating and set a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. Fourteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and an average target price of $96.17.

Read Our Latest Report on Ventas

Ventas Price Performance

The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $47.35 billion, a P/E ratio of 177.09, a PEG ratio of 2.07 and a beta of 0.70. The company has a fifty day simple moving average of $87.44 and a two-hundred day simple moving average of $84.31.

Ventas (NYSE:VTR – Get Free Report) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period last year, the business posted $0.84 EPS. The firm’s revenue for the quarter was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Sell-side analysts expect that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. Ventas’s payout ratio is presently 378.18%.

Insider Activity at Ventas

In other news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by company insiders.

Hedge Funds Weigh In On Ventas

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Deutsche Bank AG boosted its holdings in shares of Ventas by 0.7% in the 4th quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after purchasing an additional 27,688 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Ventas by 2.5% in the fourth quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock worth $222,000,000 after acquiring an additional 70,459 shares during the last quarter. Elevatus Welath Management lifted its stake in Ventas by 140.4% in the 4th quarter. Elevatus Welath Management now owns 95,031 shares of the real estate investment trust’s stock valued at $7,354,000 after purchasing an additional 55,501 shares during the last quarter. Pensionfund PDN bought a new position in shares of Ventas in the 4th quarter valued at $4,773,000. Finally, Norges Bank acquired a new stake in shares of Ventas during the 4th quarter valued at $474,571,000. 94.18% of the stock is owned by institutional investors and hedge funds.

About Ventas

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.